GrayMatters Health

Private

HaifaHealthcare & Life Scienceshttps://graymatters-health.com

Last Round

VC Round

Mar 20, 2023

Total Funding Raised

$12.5M

Momentum Score

50 /100

Company Overview

GrayMatters Health is a health technology company that develops digital self-neuromodulation therapeutics for mental disorders.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Medical Devices, Medical AI, Medical Imaging

Business Model

B2B

Customer Profile

Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

neuromodulation therapyPTSD treatmentneurofeedback systemdigital therapeuticsFDA-cleared deviceneurotechEEG-based neurofeedbackself-neuromodulationbehavioral health technologynon-invasive therapymental health devicebrain tech510(k) clearanceamygdala biomarkerEEG-fMRI-PatternEFP

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GrayMatters Health Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

GrayMatters Health Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Mar 20, 2023
Grant	Sep 7, 2022
Series A	Jan 11, 2022
Grant	Jul 29, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Oded Kraft

Co-founder, CEO And President

Founding Team

GrayMatters Health Investors

Notable investors and investment history

Investor	Rounds
European Innovation Council	Grant
Joy Ventures	Series A
BIRD Foundation	Grant
J Ventures	Series A
J-Impact	Series A
Corundum Neuroscience	Series A
EIC Fund	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 15, 2025
Prism Suite is a new portfolio of solutions for mental health providers.

View all signals

GrayMatters Health Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

GrayMatters Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GrayMatters Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersHaifa

Employee Range31

Year Founded2018

Last FundingMar 20, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.